AMRI : Summary for Albany Molecular Research, Inc. - Yahoo Finance

U.S. Markets closed

Albany Molecular Research, Inc. (AMRI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.69-0.04 (-0.29%)
At close: 4:00PM EDT

13.69 0.00 (0.01%)
After hours: 5:00PM EDT

People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close13.73
Bid0.00 x
Ask13.84 x 1100
Day's Range13.55 - 13.82
52 Week Range12.45 - 19.35
Avg. Volume365,995
Market Cap570.65M
PE Ratio (TTM)-7.47
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire9 days ago

    AMRI Receives CMO Leadership Awards for Excellence

    ALBANY, N.Y., March 22, 2017 /PRNewswire/ -- AMRI (AMRI), a global contract research, development and manufacturing organization that has been working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, has been recognized for its excellence as a contract manufacturing organization (CMO). AMRI  has been honored as part of the Life Science Leader's 2017 CMO Leadership Awards in five categories — capabilities, compatibility, expertise, quality and reliability. "Competing with more than 80 contract manufacturers, AMRI is honored to be recognized by our customers from industry pharma and biopharma companies," said William S. Marth, president and CEO, AMRI.

  • 3 Biotech Stocks to Buy in March
    Motley Fool20 days ago

    3 Biotech Stocks to Buy in March

    Why Spark Therapeutics, Albany Molecular Research, and Concert Pharmaceuticals could be great biotech stocks to buy as spring approaches.

  • PR Newswire28 days ago

    AMRI to Present at Barclays Global Healthcare Conference

    ALBANY, N.Y., March 3, 2017 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer, will present at the Barclays Global ...